⚡ Black Friday Offer: Click here and shop now!

TextRanch

The best way to perfect your writing.

Discover why 1,062,726 users count on TextRanch to get their English corrected!

1. Input your text below.
2. Get it corrected in a few minutes by our editors.
3. Improve your English!

One of our experts will correct your English.

Our experts

statistically significantly different vs significantly statistically different

The phrase 'statistically significantly different' is the correct and commonly used construction in English. The phrase 'significantly statistically different' is not correct and is not commonly used.

Last updated: March 27, 2024 • 1209 views

statistically significantly different

This phrase is correct and commonly used in English.

This phrase is used to describe a significant difference between groups or variables that has been determined through statistical analysis.

Examples:

  • The two groups were statistically significantly different in terms of their average scores.
  • The results showed that the treatment and control groups were statistically significantly different.
  • The study found that the two populations were statistically significantly different in terms of income levels.
  • However, this increase was not statistically significantly different from male control mice by appropriate tests.
  • Fold-change at one concentration is statistically significantly different from the SC
  • In clinical trials, the incidence of parkinsonism and dystonia in olanzapine-treated patients was numerically higher, but not statistically significantly different from placebo.
  • Cholecystectomy rates for raloxifene (2.3%) were not statistically significantly different from placebo (2.0%).
  • Response rates were statistically significantly higher with Thymanax compared with placebo.
  • Response and remission rates were also statistically significantly higher with XERISTAR compared with placebo.
  • The rate of treatment success was statistically significantly higher for micafungin than fluconazole (1.6% versus 2.4% breakthrough infections).
  • Ritonavir pharmacokinetic parameters were not statistically significantly associated with body weight or lean body mass.
  • Response and remission rates were also statistically significantly higher with CYMBALTA compared with placebo.
  • In all five studies, patients randomized to the Raptiva group achieved statistically significantly better responses than placebo on the primary endpoint.
  • Pre-planned interim analyses of both studies showed that lenalidomide/dexamethasone was statistically significantly superior (p < 0.00001) to dexamethasone alone for the primary efficacy endpoint, TTP.
  • Etoricoxib was associated with a statistically significantly lower rate of discontinuations due to hepatic- related adverse experiences than diclofenac.
  • In the study, the incidence of discontinuations due to hypertension-related adverse events was statistically significantly higher for etoricoxib than for diclofenac.
  • In clinical trials these events occurred statistically significantly more frequently during treatment with Remeron than with placebo.
  • The incidence of clinical gastrointestinal events leading to withdrawal was statistically significantly lower for etoricoxib versus diclofenac (7.1% versus 9.1%, respectively).
  • Etoricoxib was associated with a statistically significantly lower rate of withdrawals than diclofenac (0.3% versus 5.2%), due largely to elevations in liver function tests.
  • The following covariates were statistically significantly associated with a decreased risk of developing diarrhea: increasing cumulative capecitabine dose (0.1*kg) and increasing relative dose intensity in the first six weeks.
  • Through 48 weeks of therapy, a statistically significantly higher proportion of patients in the lopinavir/ritonavir arm had HIV-1 RNA < 50 copies/ml compared to the nelfinavir arm.
  • These clinical findings, along with the high levels of patient satisfaction with treatment, were consistently statistically significantly superior to those seen with placebo.
  • Through 48 weeks of therapy, a statistically significantly higher proportion of patients in the Kaletra arm had HIV RNA < 50 copies/ ml compared to the nelfinavir arm.

significantly statistically different

This phrase is not correct in English and is not commonly used.

  • Fold-change at one concentration is statistically significantly different from the SC
  • However, this increase was not statistically significantly different from male control mice by appropriate tests.
  • In clinical trials, the incidence of parkinsonism and dystonia in olanzapine-treated patients was numerically higher, but not statistically significantly different from placebo.
  • Cholecystectomy rates for raloxifene (2.3%) were not statistically significantly different from placebo (2.0%).
  • MI and RI were not statistically different between the fondaparinux and enoxaparin treatment groups.
  • Both dose regimens were effective and not statistically different from thyroid hormone withdrawal in stimulating radioiodine uptake for diagnostic imaging.
  • If there are no indications of statistically different sensitivities of sexes, male and female results may be pooled for statistical analyses.
  • The efficacy data show that Rapinyl is statistically different from placebo in the treatment of BTP and these results seem clinically relevant.
  • The effects on the incidence of MI and RI were not statistically different between the fondaparinux and enoxaparin treatment groups.
  • The percentage of patients with hypercalciuria at the end of the 24-week extension was not statistically different between treatment groups.
  • Animals should be assigned to groups (both control and treatment) by randomised weight distribution, so that mean body weight of each group is not statistically different from any other group.
  • A test chemical is judged to be positive if the fold induction is statistically different (p <= 0,05) from the solvent control at two adjacent concentrations in at least two independent runs (Table 7).
  • 8 infarction, clopidogrel was numerically inferior, but not statistically different from ASA (RRR = -4.0%; CI: -22.5 to 11.7 [p=0.639]).
  • In patients who were enrolled in the trial on the sole basis of a recent myocardial infarction, clopidogrel was numerically inferior, but not statistically different from ASA (RRR = -4.0%; CI: -22.5 to 11.7 [p=0.639]).
  • LOEC is the Lowest Observed Effect Concentration, the lowest concentration level at which the assay response is statistically different from that of the solvent control.

Related Comparisons

What Our Customers Are Saying

Our customers love us! We have an average rating of 4.79 stars based on 283,125 votes.
Also check out our 2,100+ reviews on TrustPilot (4.9TextRanch on TrustPilot).

Why choose TextRanch?

Lowest prices
Up to 50% lower than other online editing sites.

Fastest Times
Our team of editors is working for you 24/7.

Qualified Editors
Native English experts for UK or US English.

Top Customer Service
We are here to help. Satisfaction guaranteed!

×

⚡️ Black Friday 2024 ⚡️

Stock up on credits for the entire year!

Grab this offer now!